Dyskeratosis congenita natural history, complications and prognosis

Dyskeratosis congenita Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Dyskeratosis Congenita from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Dyskeratosis congenita natural history, complications and prognosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Dyskeratosis congenita natural history, complications and prognosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Dyskeratosis congenita natural history, complications and prognosis
CDC on Dyskeratosis congenita natural history, complications and prognosis
Dyskeratosis congenita natural history, complications and prognosis in the news
Blogs on Dyskeratosis congenita natural history, complications and prognosis
Directions to Hospitals Treating Dyskeratosis congenita
Risk calculators and risk factors for Dyskeratosis congenita natural history, complications and prognosis

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Complications

Complications include:

• Conjunctivitis, blepharitis, lacrimal duct stenosis, and pterygium
• Mandibular hypoplasia, osteoporosis, avascular necrosis, and scoliosis
• Cirrhosis
• Bone marrow failure - infections, bleeding
• Pulmonary fibrosis
• Dysphagia, dysuria, phimosis, and epiphora - due to constriction and stenosis can occur at the sites of leukoplakia
• Increased risk of malignancy - increased prevalence of malignant mucosal neoplasms, particularly squamous cell carcinoma of the mouth, nasopharynx, esophagus, rectum, vagina, or cervix. These often occur within sites of leukoplakia. The prevalence of squamous cell carcinoma of the skin is also increased.
• Death - due to infections, bleeding

Prognosis

Prognosis of the disease is poor with a mean survival of 30 years. Prognosis is worse for X-linked and autosomal recessive forms compared to autosomal dominant form.